Health Economics and Outcomes Research (United Kingdom)
Papers in the tracked journals with an author at Health Economics and Outcomes Research (United Kingdom): per year and category, where they are published, the institutions its researchers write with, and its most-cited papers. A paper counts as corporate when at least one of its authors is affiliated with an institution that OpenAlex classifies as a company; it counts once for each company among its authors' affiliations. Universities are the institutions OpenAlex classifies as education. Also as Markdown.
Key findings#
- From 2017 to 2026 (so far), authors at Health Economics and Outcomes Research (United Kingdom) took part in 28 papers in the tracked journals, most of them in health economics and policy (28).
- 4 of them were published in 2025, against 2 in 2017.
- Since 2023, the institutions with the most of these papers were King's College London (3), Novo Nordisk (Denmark) (3) and Cleveland Clinic (2).
- The journals publishing most of them were PharmacoEconomics (7), PharmacoEconomics - Open (6) and Applied Health Economics and Health Policy (1).
- The most-cited of them is “Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation” (PharmacoEconomics, 2017), with 65 citations.
Papers per year#
20172026 (so far)
| Category | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (so far) |
|---|---|---|---|---|---|---|---|---|---|---|
| Health Economics and Policy | 2 | 0 | 1 | 4 | 2 | 3 | 3 | 4 | 4 | 5 |
| All categories | 2 | 0 | 1 | 4 | 2 | 3 | 3 | 4 | 4 | 5 |
Where the papers come from#
| # | Journal | Papers |
|---|---|---|
| 1 | PharmacoEconomics | 7 |
| 2 | PharmacoEconomics - Open | 6 |
| 3 | Applied Health Economics and Health Policy | 1 |
| 4 | Cost Effectiveness and Resource Allocation | 1 |
| 5 | Health Economics Review | 1 |
| # | Institution | Papers |
|---|---|---|
| 1 | King's College London | 3 |
| 2 | Novo Nordisk (Denmark) | 3 |
| 3 | Cleveland Clinic | 2 |
| 4 | Guy's and St Thomas' NHS Foundation Trust | 2 |
| 5 | Ospedale Papa Giovanni XXIII | 2 |
| 6 | Pfizer (United Kingdom) | 2 |
| 7 | Antwerp University Hospital | 1 |
| 8 | AstraZeneca (Spain) | 1 |
| 9 | AstraZeneca (United Kingdom) | 1 |
| # | Country | Papers |
|---|---|---|
| 1 | United Kingdom | 16 |
| 2 | United States | 9 |
| 3 | Denmark | 4 |
| 4 | Italy | 3 |
| 5 | Belgium | 2 |
| 6 | Australia | 1 |
| 7 | Bangladesh | 1 |
| 8 | Canada | 1 |
| 9 | Switzerland | 1 |
| 10 | Chile | 1 |
| # | Keyword | Papers |
|---|---|---|
| 1 | cost-effectiveness | 8 |
| 2 | quality-adjusted life years | 7 |
| 3 | health economic modelling | 3 |
| 4 | obesity | 3 |
| 5 | overweight | 3 |
| 6 | type 2 diabetes | 3 |
| 7 | Italian healthcare system | 2 |
| 8 | SELECT trial | 2 |
| 9 | acute coronary syndrome | 2 |
| 10 | antimicrobial resistance | 2 |
Most-cited papers#
Cite this page
Scholar4AI. (2026). Health Economics and Outcomes Research (United Kingdom). Journal Research Rankings. Retrieved October 31, 2026, from https://scholar4ai.com/companies/health-economics-and-outcomes-research-united-kingdom
@misc{scholar4ai-companies-health-economics-and-outcomes-research-united-kingdom,
author = {{Scholar4AI}},
title = {Health Economics and Outcomes Research (United Kingdom)},
year = {2026},
howpublished = {\url{https://scholar4ai.com/companies/health-economics-and-outcomes-research-united-kingdom}},
urldate = {2026-10-31},
note = {Journal Research Rankings; data from OpenAlex (CC0); licensed CC BY-NC 4.0}
}